Do combined assays of serum AFP, AFP-L3, DCP, GP73, and DKK-1 efficiently improve the clinical values of biomarkers in decision-making for hepatocellular carcinoma? A meta-analysis
GastroenterologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Expert review of gastroenterology & hepatology
- Publicado em
- 18 mar 2021
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Do combined assays of serum AFP, AFP-L3, DCP, GP73, and DKK-1 efficiently improve the clinical values of biomarkers in decision-making for hepatocellular carcinoma? A meta-analysis
Yong-Sheng Fang, Qiang Wu, Hong-Chuan Zhao, Yuan Zhou, Lei Ye, Sheng-Sheng Liu, Xiao-Xue Li, Wei-Dong Du
Descritores MeSH
- Biomarkers, Tumor
- Carcinoma, Hepatocellular
- Liver Neoplasms
- Membrane Proteins
- Protein Precursors
- Prothrombin
- ROC Curve
- Biomarkers
- Clinical Decision-Making
- Intercellular Signaling Peptides and Proteins
Veja também
Estudos relacionados
- Meta-analysis of the GALAD model for diagnosing primary hepatocellular carcinoma
- Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis
- Clinical utility of serum fucosylated fraction of alpha-fetoprotein in the diagnostic of hepatocellular carcinoma: a comprehensive analysis with large sample size
- Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial